National Institute of Diabetes and Digestive and Kidney Disorders; Notice of Closed Meeting, 32107 [06-5068]
Download as PDF
<![CDATA[
Federal Register / Vol. 71, No. 106 / Friday, June 2, 2006 / Notices
2006, 8 a.m. to June 23, 2006, 6 p.m.
The Fairmont Washington, DC, 2401 M
Street, NW., Washington, DC 20037,
which was published in the Federal
Register on May 3, 2006, 71, FR: 06–
4149.
This meeting was scheduled for June
22–23, 2006 and has been changed to a
one day meeting on June 22, 2006; 8
a.m. to 6 p.m. The meeting is closed to
the public.
Dated: May 25, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–5061 Filed 6–1–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute of Diabetes and
Digestive and Kidney Disorders;
Notice of Closed Meeting
National Institutes of Health
jlentini on PROD1PC65 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2) notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The purpose of this
meeting is to evaluate requests for
preclinical development resources for
potential new therapeutics for type 1
diabetes. The outcome of the evaluation
will be a decision whether NIDDK
should support the request and make
available contract resources for
development of the potential
therapeutic to improve the treatment or
prevent the development of type 1
diabetes and its complications. The
research proposals and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the proposed research
projects, the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Type 1 Diabetes—
Rapid Access to Intervention Development
Special Emphasis Panel, National Institute of
Diabetes and Digestive and Kidney Diseases.
Date: June 22, 2006.
Time: 11:30 a.m. 2 p.m.
Agenda: To evaluate requests for
preclinical development resources for
potential new therapeutics for type 1 diabetes
and its complications.
18:05 Jun 01, 2006
Jkt 208001
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 98.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: May 25, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–5068 Filed 6–1–06; 8:45 am]
BILLING CODE 4140–01–M
National Institutes of Health
VerDate Aug<31>2005
Place: 6707 Democracy Boulevard,
Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Dr. Myrlene Staten, Senior
Advisory, Diabetes Translation Research,
Division of Diabetes, Endocrinology and
Metabolic Diseases, NIDDK, NIH, 6707
Democracy Boulevard, Bethesda, MD 20892–
5460. 301 402–7886.
National Institute of Child Health and
Human Development; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development Initial
Review Group; Population Sciences
Subcommittee.
Date: June 15–16, 2006.
Time: 8 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Watergate, 2650 Virginia
Avenue, NW., Washington, DC 20037.
Contact Person: Carla T. Walls, PhD,
Scientific Review Administrator, Division of
Scientific Review, National Institute of Child
Health, and Human Development, NIH, 6100
Executive Blvd., Room 5B01, Bethesda, MD
20892. (301) 435–6898. wallsc@mail.nih.gov.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Energy
Dysregulation.
Date: June 15, 2006.
PO 00000
Frm 00080
Fmt 4703
Sfmt 4703
32107
Time: 8:30 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: Rita Anand, PhD,
Scientific Review Administrator, Division of
Scientific Review, National Institute of Child
Health, and Human Development, NIH, 6100
Executive Blvd. Room 5B01, Bethesda, MD
20892. (301) 496–1487.
anandr@mail.nih.gov.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Youth Weight and
Obesity: Gender and Racial Disparities.
Date: June 16, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: Michele C. HindiAlexander, PhD, Division of Scientific
Review, National Institutes of Health,
National Institute for Child Health, and
Human Development, 6100 Executive
Boulevard, Room 5B01, Bethesda, MD
20812–7510. (301) 435–8382.
hindialm@mail.nih.gov.
Name of Committee: National Institute of
Child Health and Human Development Initial
Review Group; Function, Integration, and
Rehabilitation Sciences Subcommittee.
Date: June 19, 2006.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place; Ritz Carlton Hotel, 1150 22nd Street,
NW., Washington, DC 20037.
Contact Person: Anne Krey, Scientific
Review Administrator, Division of Scientific
Review, National Institutes of Child Health,
and Human Development, NIH, 6100
Executive Blvd., Room 5B01, Bethesda, MD
20892. (301) 435–6908. ak41o@nih.gov..
Name of Committee: National Institute of
Child Health and Human Development Initial
Review Group; Obstetrics and Maternal-Fetal
Biology Subcommittee.
Date: June 19, 2006.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place; Holiday Inn—Gaithersburg, 2
Montgomery Village Avenue, Gaithersburg,
MD, 20879.
Contact Person: Gopal M. Bhatnagar, PhD,
Scientific Review Administrator, National
Institutes of Child Health, and Human
Development, National Institutes of Health,
6100 Bldg Rm 5B01, Rockville, MD 20852.
(301) 435–6889. bhatnagg@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
E:\FR\FM\02JNN1.SGM
02JNN1
]]>Agencies
[Federal Register Volume 71, Number 106 (Friday, June 2, 2006)]
[Notices]
[Page 32107]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-5068]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney
Disorders; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2) notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The purpose of this meeting is to evaluate requests
for preclinical development resources for potential new therapeutics
for type 1 diabetes. The outcome of the evaluation will be a decision
whether NIDDK should support the request and make available contract
resources for development of the potential therapeutic to improve the
treatment or prevent the development of type 1 diabetes and its
complications. The research proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the proposed research projects, the disclosure of which
would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Type 1 Diabetes--Rapid Access to Intervention
Development Special Emphasis Panel, National Institute of Diabetes
and Digestive and Kidney Diseases.
Date: June 22, 2006.
Time: 11:30 a.m. 2 p.m.
Agenda: To evaluate requests for preclinical development
resources for potential new therapeutics for type 1 diabetes and its
complications.
Place: 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Dr. Myrlene Staten, Senior Advisory, Diabetes
Translation Research, Division of Diabetes, Endocrinology and
Metabolic Diseases, NIDDK, NIH, 6707 Democracy Boulevard, Bethesda,
MD 20892-5460. 301 402-7886.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 98.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: May 25, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-5068 Filed 6-1-06; 8:45 am]
BILLING CODE 4140-01-M
